NO820836L - Fremgangsmaate for immunoanalyse under anvendelse av monoklone antistoffer - Google Patents
Fremgangsmaate for immunoanalyse under anvendelse av monoklone antistofferInfo
- Publication number
- NO820836L NO820836L NO820836A NO820836A NO820836L NO 820836 L NO820836 L NO 820836L NO 820836 A NO820836 A NO 820836A NO 820836 A NO820836 A NO 820836A NO 820836 L NO820836 L NO 820836L
- Authority
- NO
- Norway
- Prior art keywords
- igg
- specific
- sample
- antibody
- antigen
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 17
- 238000004458 analytical method Methods 0.000 title description 2
- 239000000427 antigen Substances 0.000 claims description 18
- 102000036639 antigens Human genes 0.000 claims description 18
- 108091007433 antigens Proteins 0.000 claims description 18
- 108060003951 Immunoglobulin Proteins 0.000 claims description 16
- 102000018358 immunoglobulin Human genes 0.000 claims description 16
- 230000000890 antigenic effect Effects 0.000 claims description 14
- 238000002360 preparation method Methods 0.000 claims description 13
- 102000004169 proteins and genes Human genes 0.000 claims description 10
- 108090000623 proteins and genes Proteins 0.000 claims description 10
- 229920002521 macromolecule Polymers 0.000 claims description 6
- 229940072221 immunoglobulins Drugs 0.000 claims description 5
- 230000015572 biosynthetic process Effects 0.000 claims description 4
- 238000001556 precipitation Methods 0.000 claims description 3
- 229940027941 immunoglobulin g Drugs 0.000 description 30
- 238000006243 chemical reaction Methods 0.000 description 8
- 239000012634 fragment Substances 0.000 description 7
- 210000002966 serum Anatomy 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000018071 Immunoglobulin Fc Fragments Human genes 0.000 description 2
- 108010091135 Immunoglobulin Fc Fragments Proteins 0.000 description 2
- 102000015094 Paraproteins Human genes 0.000 description 2
- 108010064255 Paraproteins Proteins 0.000 description 2
- 241001494479 Pecora Species 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 229920001184 polypeptide Polymers 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 102000001706 Immunoglobulin Fab Fragments Human genes 0.000 description 1
- 108010054477 Immunoglobulin Fab Fragments Proteins 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 206010035226 Plasma cell myeloma Diseases 0.000 description 1
- 241000276498 Pollachius virens Species 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 230000004520 agglutination Effects 0.000 description 1
- 230000009833 antibody interaction Effects 0.000 description 1
- 230000009831 antigen interaction Effects 0.000 description 1
- 238000000149 argon plasma sintering Methods 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 239000008366 buffered solution Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000002163 immunogen Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 201000000050 myeloid neoplasm Diseases 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54393—Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/577—Immunoassay; Biospecific binding assay; Materials therefor involving monoclonal antibodies binding reaction mechanisms characterised by the use of monoclonal antibodies; monoclonal antibodies per se are classified with their corresponding antigens
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/815—Test for named compound or class of compounds
Landscapes
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Materials By Optical Means (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8023151 | 1980-07-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO820836L true NO820836L (no) | 1982-03-15 |
Family
ID=10514792
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO820836A NO820836L (no) | 1980-07-16 | 1982-03-15 | Fremgangsmaate for immunoanalyse under anvendelse av monoklone antistoffer |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US4618589A (cs) |
| EP (1) | EP0044219A1 (cs) |
| JP (1) | JPS57501147A (cs) |
| DK (1) | DK99682A (cs) |
| NO (1) | NO820836L (cs) |
| WO (1) | WO1982000364A1 (cs) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0235944B2 (cs) * | 1980-06-20 | 1990-08-14 | Unilever Nv | |
| US4879219A (en) * | 1980-09-19 | 1989-11-07 | General Hospital Corporation | Immunoassay utilizing monoclonal high affinity IgM antibodies |
| GB2115005B (en) * | 1981-12-03 | 1984-11-14 | Cancer Research Campaign | Anti rat liver monoclonal antibody |
| GB2118300B (en) * | 1982-02-12 | 1985-06-19 | Corning Glass Works | Method of immunoassay |
| US4792528A (en) * | 1982-05-21 | 1988-12-20 | The Trustees Of Columbia University In The City Of New York | Methods for obtaining monoclonal antibodies useful in enhanced sensitivity immunoassays |
| US4514505A (en) * | 1982-05-21 | 1985-04-30 | The Trustees Of Columbia University In The City Of New York | Monoclonal antibody mixtures and use thereof for enhanced sensitivity immunoassays |
| US4471058A (en) * | 1982-07-26 | 1984-09-11 | Board Of Trustees Operating Michigan State University | Method for the detection and/or determination of a polyvalent antigen using at least two different monoclonal antibodies |
| US4828981A (en) * | 1983-08-24 | 1989-05-09 | Synbiotics Corporation | Immunoassays for determining Dirofilaria immitis infection using antiidiotype monoclonal antibody reagents |
| US4690890A (en) * | 1984-04-04 | 1987-09-01 | Cetus Corporation | Process for simultaneously detecting multiple antigens using dual sandwich immunometric assay |
| JPH0736016B2 (ja) * | 1984-05-11 | 1995-04-19 | 和光純薬工業株式会社 | 免疫グロブリンの定量方法 |
| US4841024A (en) * | 1986-09-15 | 1989-06-20 | Becton Dickinson And Company | Purification of antibodies |
| JP2617299B2 (ja) * | 1986-09-17 | 1997-06-04 | ダイナボット 株式会社 | エラスターゼ1の免疫学的測定方法 |
| US4983530A (en) * | 1988-01-29 | 1991-01-08 | E. I. Du Pont De Nemours And Company | Sandwich immunoassay for determination of total monoclonal IGG |
| IT1216698B (it) * | 1988-04-01 | 1990-03-08 | New Scient Co Spa | Metodo per la determinazione della presenza di catene leggere libere in campioni di urina, complesso di preparati per l'esecuzione del metodo, e relativo reagente. |
| JPH01301165A (ja) * | 1988-05-30 | 1989-12-05 | Sekisui Chem Co Ltd | 免疫測定法 |
| US5063081A (en) * | 1988-11-14 | 1991-11-05 | I-Stat Corporation | Method of manufacturing a plurality of uniform microfabricated sensing devices having an immobilized ligand receptor |
| GB8900252D0 (en) * | 1989-01-06 | 1989-03-08 | Kodak Ltd | Removal of an antigenic substance from a fluid |
| US5888749A (en) * | 1990-12-20 | 1999-03-30 | Iatron Laboratories, Inc. | Anti-human plasmin-α2 -plasmin inhibitor complex antibodies, hybridomas, and immunological determination method |
| JP2004045384A (ja) * | 2002-05-22 | 2004-02-12 | Matsushita Electric Ind Co Ltd | 免疫学的測定方法、免疫学的測定装置、生体成分測定用トイレ、抗アルブミンモノクローナル抗体、それを産生する細胞株、およびアルブミン検出キット |
| GB0501741D0 (en) | 2005-01-27 | 2005-03-02 | Binding Site The Ltd | Antibody |
| JP5448424B2 (ja) * | 2007-11-20 | 2014-03-19 | タカラバイオ株式会社 | ヒトIgGのFcを含有するタンパク質の測定試薬 |
| GB0914535D0 (en) * | 2009-08-19 | 2009-09-30 | Binding Site Group The Ltd | Prognosis assay |
| EP2564188A4 (en) | 2010-04-26 | 2013-09-25 | Merrimack Pharmaceuticals Inc | TESTS FOR ANTI-MEDICATION ANTIBODIES IN THE PRESENCE OF ENDOGENOUS PROTEIN COMPOUNDS OF THE MEDICINAL PRODUCT |
| GB201012049D0 (en) | 2010-07-19 | 2010-09-01 | Binding Site Group The Ltd | Competition assay |
| CN108350450B (zh) * | 2015-11-09 | 2022-07-05 | 国立大学法人京都工艺纤维大学 | 人血清来源的IgG多克隆抗体的分离剂、以及使用其的人血清来源的IgG多克隆抗体的分离方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL7501215A (nl) * | 1975-02-01 | 1976-08-03 | Akzo Nv | Methode voor het aantonen en bepalen van een antigeen of antilichaam. |
| JPS605899B2 (ja) * | 1975-04-10 | 1985-02-14 | 中外製薬株式会社 | 免疫化学的定量法 |
| US4273756A (en) * | 1978-07-28 | 1981-06-16 | Abbott Laboratories | Immunoassay for class specific antibodies |
| US4292403A (en) * | 1978-08-24 | 1981-09-29 | Akzona Incorporated | Detection and/or determination of IgM, IgA, IgD and IgE immunoglobulins |
| CA1142466A (en) * | 1979-01-09 | 1983-03-08 | Cesar Milstein | Cell lines |
| US4236893A (en) * | 1979-04-09 | 1980-12-02 | Minnesota Mining And Manufacturing Company | Method for the assay of classes of antigen-specific antibodies |
| US4349528A (en) * | 1979-11-21 | 1982-09-14 | The Wistar Institute | Monocolonal hybridoma antibody specific for high molecular weight carcinoembryonic antigen |
| CA1160566A (en) * | 1980-04-25 | 1984-01-17 | Harald Gallati | Immunological determination method |
| JPS56159718A (en) * | 1980-05-15 | 1981-12-09 | Canon Inc | Small-sized electronic computer |
| US4376110A (en) * | 1980-08-04 | 1983-03-08 | Hybritech, Incorporated | Immunometric assays using monoclonal antibodies |
-
1981
- 1981-07-13 EP EP81303203A patent/EP0044219A1/en not_active Ceased
- 1981-07-13 WO PCT/GB1981/000136 patent/WO1982000364A1/en not_active Ceased
- 1981-07-13 JP JP56502348A patent/JPS57501147A/ja active Pending
-
1982
- 1982-03-08 DK DK99682A patent/DK99682A/da not_active Application Discontinuation
- 1982-03-15 NO NO820836A patent/NO820836L/no unknown
-
1985
- 1985-06-19 US US06/745,837 patent/US4618589A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US4618589A (en) | 1986-10-21 |
| WO1982000364A1 (en) | 1982-02-04 |
| JPS57501147A (cs) | 1982-07-01 |
| DK99682A (da) | 1982-03-08 |
| EP0044219A1 (en) | 1982-01-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO820836L (no) | Fremgangsmaate for immunoanalyse under anvendelse av monoklone antistoffer | |
| Uotila et al. | Two-site sandwich enzyme immunoassay with monoclonal antibodies to human alpha-fetoprotein | |
| Faaber et al. | Cross-reactivity of anti-DNA antibodies with proteoglycans | |
| Seligmann et al. | Immunochemical studies in four cases of alpha chain disease | |
| Beutner et al. | Quantitative studies of immunofluorescent staining: relationships of characteristics of unabsorbed antihuman IgG conjugates to their specific and non-specific staining properties in an indirect test for antinuclear factors | |
| AU616484B2 (en) | Method for determination of a polyvalent substance using an immunoaggregate | |
| Delacroix et al. | Influence of molecular size of IgA on its immunoassay by various techniques. II. Solid-phase radioimmunoassays | |
| Møller | Fc-mediated immune precipitation. I. A new role of the Fc-portion of IgG | |
| AU633115B2 (en) | Oxidative denaturation of protein analytes | |
| EP0119767B1 (en) | Method of measuring ligands | |
| CH649306A5 (de) | Traegergebundenes immunglobulin-spaltprodukt und seine verwendung fuer immunologische analysenverfahren. | |
| Fremy et al. | Policy on characterization of antibodies used in immunochemical methods of analysis for mycotoxins and phycotoxins | |
| Azimzadeh et al. | Operational aspects of antibody affinity constants measured by liquid‐phase and solid‐phase assays | |
| Jefferis et al. | Quantitation of human total IgG, kappa IgG and lambda IgG in serum using monoclonal antibodies | |
| Caponi et al. | Free light chain UV quantification compared with immunochemical measurement: how dimers and monomers may influence the results | |
| Aarli | Myasthenia gravis: antibodies to an acid-soluble antigen in striated muscle | |
| NO164135B (no) | Immunometrisk metode for bestemmelse av et hapten, samt analysesett for utfoerelse av metoden. | |
| Hagenaars et al. | Comparison of ELISA and toxin neutralization for the determination of tetanus antibodies | |
| US5130234A (en) | Method of quantitative determination utilizing enzyme aggregation | |
| Beck et al. | Nephelometry of human IgG subclass concentration in serum. | |
| Milgrom et al. | Comparison of various procedures for the detection of antigen-antibody complexes | |
| US4476230A (en) | Process for the kinetic determination of immunocomplexes | |
| Breton et al. | Apparent discrepancies between immunochemical methods used for ovalbumin recognition in food | |
| Borsos et al. | Immunoassay of antigens and haptens by inhibition of passive immune hemolysis | |
| Heino et al. | Turbidimetric measurement of Bence-Jones proteins using antibodies against free light chains of immunoglobulins. An artifact caused by different polymeric forms of light chains |